1. 1. The actions of several metabotropic glutamate receptor agonists and antagonists on noradrenaline (NA)-stimulated [ 3H]-cyclic AMP accumulation were investigated in rat cerebral cortical slices. 2. 2. Quisqualate (QUIS), L-2-amino-3-phosphonopropionic acid (L-AP3) and glutamate (GLU) elicited concentration-dependent inhibition of (NA)-stimulated [ 3H]-cyclic AMP accumulation, with IC 50 values of 105 ± 29, 275 ± 36 and 944 ± 150 μM respectively. In contrast (Rs)-α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) (0.5 mM) and N-methyl-D-aspartic acid (NMDA) (0.5 mM) had no effect. 3. 3. (2S,3S,4S)-α-(Carboxycyclopropyl)glycine (L-CCGI), 1-Aminocyclo-pentane-lS,3R-dicarbo-xylate (1S,3R-ACPD), ibotenate (IBO) and (RS)-4-carboxy-3-hydroxy-phenylglycine (CHPG)elicited a concentration-dependent enhancement ofNA-stimulated [ 3H]-cyclic AMP accumulation, with EC 50 values of 2.5 ± 0.11, 42 ± 1.3, 97.8 ± 2.1 and 157 ± 13.4 μM, respectively. 4. 4. (S)-3-carboxy-4-hydroxyphenylglycine (3C4HPG) and (S)-4-carboxy-3-hydroxyphenyl-glycine (4C3HPG) produced a biphasic effect, at concentrations up to 100 and 500 μM, respectively, they significantly enhanced the action of NA (100 μM), at ImM concentration both compounds as well as α-methyl-4-carboxyphenylglycine (MCPG) produced a significant inhibition of NA-stimulated cyclic AMP accumulation. 5. 5. A putative mGluR antagonist — L-AP3, inhibited the 1S,3R-ACPD (100 μM) induced enhancement of the action of NA (100 μM) on [ 3H]-cyclic AMP accumulation in a biphasic manner with an IC 50 of 4.5 μM for the high affinity site, which represented 65% of the total and an IC 50 of 283 μM for the low affinity site. 6. 6. β-adrenoceptor antagonist propranolol inhibited the interaction between 1S,3R-ACPD (100 μM) and NA (100 μM) on [ 3H]-cyclic AMP accumulation by about 80%, with an IC 50 of 0.52 ± 0.011 μM, to the level observed after 1S,3R-ACPD alone. Prazosin, an α 1-adrenoceptor antagonist was more potent (IC 50 of 0.091 ± 0.012 μM) but less efficacious (60% inhibition) as an inhibitor of the interaction either between NA and 1S,3R-ACPD while yohimbine, na α 2-adrenoceptor antagonist (up to 1 μM) had no effect. 7. 7. Neither the protein kinase C inhibitor — staurosporine (10 μM) nor thapsigargin (1 μM), which depletes IP3 sensitive calcium stores, inhibited significantly the 1S,3R-ACPD (100 μM)-induced enhancement of the action of NA (100 μM) on [ 3H]-cyclic AMP accumulation. 8. 8. Adenosine deaminase (0.5 U/ml) abolished both the 1S,3R-ACPD (100 μM)-induced [ 3H]-cyclic AMP accumulation and the synergistic interaction of this compound with NA (100 μM). 9. 9. These results indicate the existence of different subtypes of metabotropic glutamate receptors in rat brain which either inhibit or enhance the NA-stimulated [ 3H]-cyclic AMP accumulation. The enhancement m cerebral cortical slices is mediated via receptors which are blocked with high affinity by L-AP3 and occurs via interactions with endogenous adenosine; the inhibition is mediated by receptors sensitive to quisqualate, L-AP3 and glutamate and may represent a predominant interaction between NA and excitatory amino acids (EAA), which in cerebral cortical slices is masked by excitatory effects.